HEALTHBBC HEALTH
Hope for thousands of MS patients as 'life-changing' drug now on NHS in England
Fampridine, a drug that boosts nerve signals to improve walking for MS patients, is now available on the NHS in England. Up to 5,000 patients are eligible for the treatment.
Related Signal
Adjacent reporting
- NHS drugs go-ahead offers lifeline to children with rare muscle-wasting disease
- Hope for thousands of ovarian cancer patients as new drug which slashes risk of death by a third is made available on the NHS
- UK launches national dementia registry to speed up search for treatments
- Thousands of cancer patients in England to benefit from new immunotherapy jab
- Drug that delays onset of type 1 diabetes approved in England and Wales